Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)-Reference-Cited by-同舟云学术

Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)

Published:2020-01-28 Issue:5 Volume:51 Page:534-543
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Takeuchi Toshihisa¹^ORCID,Furuta Takahisa²^ORCID,Fujiwara Yasuhiro³^ORCID,Sugimoto Mitsushige⁴^ORCID,Kasugai Kunio⁵,Kusano Motoyasu⁶,Okada Hiroyuki⁷,Suzuki Takahiro⁸,Higuchi Tomohiro⁸,Kagami Takuma⁸,Uotani Takahiro⁸,Yamade Mihoko⁸,Sawada Akinari³^ORCID,Tanaka Fumio³^ORCID,Harada Satoshi⁹,Ota Kazuhiro⁹,Kojima Yuichi¹,Murata Masaki⁴,Tamura Yasuhiro⁵,Funaki Yasushi⁵,Kawamura Osamu⁶,Okamoto Yuki⁷,Fujimoto Kazuma¹⁰,Higuchi Kazuhide⁹

Affiliation:

1. Endoscopic Center; Osaka Medical College Hospital; Takatsuki Japan

2. Center for Clinical Research; Hamamatsu University School of Medicine; Hamamatsu Japan

3. Department of Gastroenterology; Osaka City University Graduate School of Medicine School of Medicine; Osaka Japan

4. Division of Digestive Endoscopy; Shiga University of Medical Science Hospital; Otsu Japan

5. Department of Gastroenterology; Aichi Medical University; Aichi Japan

6. Department of Endoscopy and Endoscopic Surgery; Gunma University Hospital; Meabashi Japan

7. Department of Gastroenterology and Hepatology; Dentistry and Pharmaceutical Sciences; Okayama University Graduate School of Medicine; Okayama Japan

8. First Department of Medicine; Hamamatsu University School of Medicine; Hamamatsu Japan

9. Second Department of Internal Medicine; Osaka Medical College; Takatsuki Japan

10. Department of Internal Medicine; Saga Medical School; Saga Japan

Funder

EA Pharma Co., Ltd.,

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15641/fullpdf

Reference48 articles.

1. Update on the epidemiology of gastro-ooesophageal reflux disease: a systematic review;El-Serag;Gut,2014

2. Gastro-oesophageal reflux disease: the recent trend in Japan;Miwa;Clin J Gastroenterol,2008

3. Swedish Council on Health Technology Assessment (SBU) Dyspepsia and gastro-ooesophageal reflux: a systematic review

4. Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis;Katz;Aliment Pharmacol Ther,2007

5. Nexium® (esomeprazole) US Prescribing Information 2018 https://dailymed.nlm.nih.gov/dailymed/

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laryngopharyngeal Reflux Pathophysiology, Clinical Presentation, and Management: A Narrative Review;Cureus;2024-08-20

2. Research on drug treatment and the novel signaling pathway of chronic atrophic gastritis;Biomedicine & Pharmacotherapy;2024-07

3. Evaluating vonoprazan and tegoprazan for gastroesophageal reflux disease treatment in Chinese Healthcare: an EVIDEM framework analysis;BMC Gastroenterology;2024-06-20

4. Vonoprazan causes symptomatic improvement in non-erosive gastroesophageal reflux disease: A systematic review and meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2024-06

5. Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers;BMC Gastroenterology;2024-05-21